Pillar Pacific Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Pillar Pacific Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$6.43M	Buy	101,810 +3,621	+4%	+$225K	0.5%	76
2020 Q4	$6.09M	Sell	98,189 -1,726	-2%	-$106K	0.51%	75
2020 Q3	$6.02M	Buy	99,915 +4,540	+5%	+$273K	0.58%	67
2020 Q2	$5.61M	Buy	95,375 +13,089	+16%	+$783K	0.59%	67
2020 Q1	$4.59M	Buy	82,286 +2,275	+3%	+$139K	0.6%	70
2019 Q4	$5.14M	Buy	+80,011	New	+$4.58M	0.53%	79

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pillar Pacific Capital Management's BMY Position: Q1 2021 in Review

Pillar Pacific Capital Management increased its Bristol-Myers Squibb (BMY) stake by 3.7% in Q1 2021, buying an estimated $225K and bringing the position to 101,810 shares worth $6.43M. The position accounts for 0.5% of the portfolio, ranked #76.

Pillar Pacific Capital Management first reported a position in BMY in Q4 2019 and has held it in 6 quarters since. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Pillar Pacific Capital Management held 101,810 shares of Bristol-Myers Squibb worth $6.43M as of Q1 2021.
Pillar Pacific Capital Management bought 3,621 Bristol-Myers Squibb shares in Q1 2021, an estimated $225K.
Bristol-Myers Squibb made up 0.5% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #76 holding.
Pillar Pacific Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 6 quarters since.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.